Treatment for COVID-19

Some medications, such as chloroquine, hydroxychloroquine, remdesivir and others are being evaluated for potential use. At this time, there are no FDA-approved medications available to treat COVID-19. Please consult a licensed physician or other healthcare provider for additional recommendations about disease treatment.

Remdesivir is an investigational drug being studied as a treatment for COVID-19.  Gilead Sciences Inc., the pharmaceutical company that makes remdesivir, received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on May 1, 2020 to allow the medication to be utilized by hospitalized COVID-19 patients with severe disease.

For more information, visit:  Remdesivir Frequently Asked Questions

Yes.  Other antiviral medications are being studied to see if they might help treat COVID-19.  Therapies directed at a person’s immune system are also under study.  The use of convalescent plasma, which involves taking the plasma from a person who has recovered from COVID-19 and infusing it into a person with the illness, is being studied. For more information about therapies under investigation, please see here.

There is currently no scientific evidence to show that taking ibuprofen while sick with COVID-19 will lead to worsening illness. For persons looking for a medication to reduce their fever, acetaminophen might be preferable. Both acetaminophen and ibuprofen, like any other medication, can have serious side effects. You should consult with your healthcare provider if you are unsure what the best medication is for you.

No, it is not.  Drinking bleach or any disinfectant is VERY dangerous and can cause serious illness or death. Please consult a licensed physician or other healthcare provider for treatment recommendations.

No, it is not.  Injecting bleach or any other disinfectant is VERY dangerous and can cause serious illness or death.  Please consult a licensed physician or other healthcare provider for treatment recommendations.

Page last reviewed: June 1, 2020